TBA4A_HUMAN - dbPTM
TBA4A_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID TBA4A_HUMAN
UniProt AC P68366
Protein Name Tubulin alpha-4A chain
Gene Name TUBA4A
Organism Homo sapiens (Human).
Sequence Length 448
Subcellular Localization Cytoplasm, cytoskeleton.
Protein Description Tubulin is the major constituent of microtubules. It binds two moles of GTP, one at an exchangeable site on the beta chain and one at a non-exchangeable site on the alpha chain..
Protein Sequence MRECISVHVGQAGVQMGNACWELYCLEHGIQPDGQMPSDKTIGGGDDSFTTFFCETGAGKHVPRAVFVDLEPTVIDEIRNGPYRQLFHPEQLITGKEDAANNYARGHYTIGKEIIDPVLDRIRKLSDQCTGLQGFLVFHSFGGGTGSGFTSLLMERLSVDYGKKSKLEFSIYPAPQVSTAVVEPYNSILTTHTTLEHSDCAFMVDNEAIYDICRRNLDIERPTYTNLNRLISQIVSSITASLRFDGALNVDLTEFQTNLVPYPRIHFPLATYAPVISAEKAYHEQLSVAEITNACFEPANQMVKCDPRHGKYMACCLLYRGDVVPKDVNAAIAAIKTKRSIQFVDWCPTGFKVGINYQPPTVVPGGDLAKVQRAVCMLSNTTAIAEAWARLDHKFDLMYAKRAFVHWYVGEGMEEGEFSEAREDMAALEKDYEEVGIDSYEDEDEGEE
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
6Phosphorylation--MRECISVHVGQAG
--CCCEEEEEEHHHH
20.1615345747
10UbiquitinationECISVHVGQAGVQMG
CEEEEEEHHHHHHHC
9.2027667366
11UbiquitinationCISVHVGQAGVQMGN
EEEEEEHHHHHHHCH
33.5827667366
13UbiquitinationSVHVGQAGVQMGNAC
EEEEHHHHHHHCHHH
11.4222817900
24PhosphorylationGNACWELYCLEHGIQ
CHHHHHHHHHHCCCC
5.40-
25AcetylationNACWELYCLEHGIQP
HHHHHHHHHHCCCCC
5.868294455
38PhosphorylationQPDGQMPSDKTIGGG
CCCCCCCCCCCCCCC
46.5324275569
40AcetylationDGQMPSDKTIGGGDD
CCCCCCCCCCCCCCC
46.5124906155
41PhosphorylationGQMPSDKTIGGGDDS
CCCCCCCCCCCCCCC
29.8221712546
45UbiquitinationSDKTIGGGDDSFTTF
CCCCCCCCCCCCEEE
30.2722817900
48PhosphorylationTIGGGDDSFTTFFCE
CCCCCCCCCEEEEEE
29.2728731282
50PhosphorylationGGGDDSFTTFFCETG
CCCCCCCEEEEEECC
27.0121712546
51PhosphorylationGGDDSFTTFFCETGA
CCCCCCEEEEEECCC
16.8328102081
54S-nitrosocysteineDSFTTFFCETGAGKH
CCCEEEEEECCCCCC
3.90-
54GlutathionylationDSFTTFFCETGAGKH
CCCEEEEEECCCCCC
3.9022555962
54S-nitrosylationDSFTTFFCETGAGKH
CCCEEEEEECCCCCC
3.9020140087
54S-palmitoylationDSFTTFFCETGAGKH
CCCEEEEEECCCCCC
3.9029575903
56PhosphorylationFTTFFCETGAGKHVP
CEEEEEECCCCCCCC
33.2524732914
60AcetylationFCETGAGKHVPRAVF
EEECCCCCCCCCEEE
40.6826051181
60UbiquitinationFCETGAGKHVPRAVF
EEECCCCCCCCCEEE
40.6822817900
73PhosphorylationVFVDLEPTVIDEIRN
EEECCCCCHHHHHHC
22.25-
81AcetylationVIDEIRNGPYRQLFH
HHHHHHCCCCHHHCC
15.69-
81UbiquitinationVIDEIRNGPYRQLFH
HHHHHHCCCCHHHCC
15.6921890473
81UbiquitinationVIDEIRNGPYRQLFH
HHHHHHCCCCHHHCC
15.6932142685
83Nitrated tyrosineDEIRNGPYRQLFHPE
HHHHCCCCHHHCCHH
16.64-
83NitrationDEIRNGPYRQLFHPE
HHHHCCCCHHHCCHH
16.64-
94PhosphorylationFHPEQLITGKEDAAN
CCHHHHCCCCHHHHH
51.2828152594
96SumoylationPEQLITGKEDAANNY
HHHHCCCCHHHHHHC
43.71-
96AcetylationPEQLITGKEDAANNY
HHHHCCCCHHHHHHC
43.7130584145
96SumoylationPEQLITGKEDAANNY
HHHHCCCCHHHHHHC
43.71-
96UbiquitinationPEQLITGKEDAANNY
HHHHCCCCHHHHHHC
43.7127667366
97UbiquitinationEQLITGKEDAANNYA
HHHCCCCHHHHHHCC
54.98-
97UbiquitinationEQLITGKEDAANNYA
HHHCCCCHHHHHHCC
54.9821963094
103PhosphorylationKEDAANNYARGHYTI
CHHHHHHCCCCCCCC
9.4827155012
108PhosphorylationNNYARGHYTIGKEII
HHCCCCCCCCCHHHH
11.6825884760
109PhosphorylationNYARGHYTIGKEIID
HCCCCCCCCCHHHHH
19.9928796482
112SumoylationRGHYTIGKEIIDPVL
CCCCCCCHHHHHHHH
41.72-
112AcetylationRGHYTIGKEIIDPVL
CCCCCCCHHHHHHHH
41.7226051181
112SumoylationRGHYTIGKEIIDPVL
CCCCCCCHHHHHHHH
41.72-
112UbiquitinationRGHYTIGKEIIDPVL
CCCCCCCHHHHHHHH
41.7221906983
124"N6,N6-dimethyllysine"PVLDRIRKLSDQCTG
HHHHHHHHHHHHCCC
50.39-
124MethylationPVLDRIRKLSDQCTG
HHHHHHHHHHHHCCC
50.39-
124UbiquitinationPVLDRIRKLSDQCTG
HHHHHHHHHHHHCCC
50.39-
127UbiquitinationDRIRKLSDQCTGLQG
HHHHHHHHHCCCCCE
58.9921963094
143PhosphorylationLVFHSFGGGTGSGFT
EEEEECCCCCCCCHH
28.6032142685
148AcetylationFGGGTGSGFTSLLME
CCCCCCCCHHHHHHH
31.06-
148UbiquitinationFGGGTGSGFTSLLME
CCCCCCCCHHHHHHH
31.0621890473
148AcetylationFGGGTGSGFTSLLME
CCCCCCCCHHHHHHH
31.0619608861
148UbiquitinationFGGGTGSGFTSLLME
CCCCCCCCHHHHHHH
31.0627667366
149UbiquitinationGGGTGSGFTSLLMER
CCCCCCCHHHHHHHH
4.4921890473
149UbiquitinationGGGTGSGFTSLLMER
CCCCCCCHHHHHHHH
4.4927667366
151PhosphorylationGTGSGFTSLLMERLS
CCCCCHHHHHHHHHC
19.76-
151UbiquitinationGTGSGFTSLLMERLS
CCCCCHHHHHHHHHC
19.7621963094
158PhosphorylationSLLMERLSVDYGKKS
HHHHHHHCCCCCCCC
21.1128355574
158UbiquitinationSLLMERLSVDYGKKS
HHHHHHHCCCCCCCC
21.1121963094
161NitrationMERLSVDYGKKSKLE
HHHHCCCCCCCCCEE
28.79-
161PhosphorylationMERLSVDYGKKSKLE
HHHHCCCCCCCCCEE
28.7923911959
163AcetylationRLSVDYGKKSKLEFS
HHCCCCCCCCCEEEE
47.87129735
163MethylationRLSVDYGKKSKLEFS
HHCCCCCCCCCEEEE
47.87129735
163UbiquitinationRLSVDYGKKSKLEFS
HHCCCCCCCCCEEEE
47.8727667366
164UbiquitinationLSVDYGKKSKLEFSI
HCCCCCCCCCEEEEE
48.7521906983
165PhosphorylationSVDYGKKSKLEFSIY
CCCCCCCCCEEEEEE
46.0622817900
166UbiquitinationVDYGKKSKLEFSIYP
CCCCCCCCEEEEEEE
62.0022817900
170PhosphorylationKKSKLEFSIYPAPQV
CCCCEEEEEEECCCC
16.3123663014
172PhosphorylationSKLEFSIYPAPQVST
CCEEEEEEECCCCCE
7.6723663014
173UbiquitinationKLEFSIYPAPQVSTA
CEEEEEEECCCCCEE
35.4823000965
178PhosphorylationIYPAPQVSTAVVEPY
EEECCCCCEEEEECC
12.8523663014
179PhosphorylationYPAPQVSTAVVEPYN
EECCCCCEEEEECCC
25.3123663014
183UbiquitinationQVSTAVVEPYNSILT
CCCEEEEECCCCCCC
35.1521963094
185PhosphorylationSTAVVEPYNSILTTH
CEEEEECCCCCCCCC
14.1823663014
185UbiquitinationSTAVVEPYNSILTTH
CEEEEECCCCCCCCC
14.1822817900
187PhosphorylationAVVEPYNSILTTHTT
EEEECCCCCCCCCCC
17.0923663014
190PhosphorylationEPYNSILTTHTTLEH
ECCCCCCCCCCCCCC
18.1823663014
191PhosphorylationPYNSILTTHTTLEHS
CCCCCCCCCCCCCCC
17.4923663014
193PhosphorylationNSILTTHTTLEHSDC
CCCCCCCCCCCCCCE
30.8623663014
194PhosphorylationSILTTHTTLEHSDCA
CCCCCCCCCCCCCEE
23.6523663014
198PhosphorylationTHTTLEHSDCAFMVD
CCCCCCCCCEEEEEC
25.6326356563
199UbiquitinationHTTLEHSDCAFMVDN
CCCCCCCCEEEEECH
29.6721963094
210PhosphorylationMVDNEAIYDICRRNL
EECHHHHHHHHHCCC
13.3025884760
217UbiquitinationYDICRRNLDIERPTY
HHHHHCCCCCCCCCH
7.1427667366
223PhosphorylationNLDIERPTYTNLNRL
CCCCCCCCHHCHHHH
49.5528796482
224PhosphorylationLDIERPTYTNLNRLI
CCCCCCCHHCHHHHH
9.0519605366
225PhosphorylationDIERPTYTNLNRLIS
CCCCCCHHCHHHHHH
35.3928555341
232PhosphorylationTNLNRLISQIVSSIT
HCHHHHHHHHHHHHH
20.6021712546
236PhosphorylationRLISQIVSSITASLR
HHHHHHHHHHHHHCC
20.0423403867
237PhosphorylationLISQIVSSITASLRF
HHHHHHHHHHHHCCC
17.0523403867
239PhosphorylationSQIVSSITASLRFDG
HHHHHHHHHHCCCCC
16.4923403867
241PhosphorylationIVSSITASLRFDGAL
HHHHHHHHCCCCCCC
16.0723403867
241UbiquitinationIVSSITASLRFDGAL
HHHHHHHHCCCCCCC
16.0727667366
248UbiquitinationSLRFDGALNVDLTEF
HCCCCCCCCCCCCEE
8.6321963094
253PhosphorylationGALNVDLTEFQTNLV
CCCCCCCCEEECCCC
30.2321712546
257PhosphorylationVDLTEFQTNLVPYPR
CCCCEEECCCCCCCC
35.5221712546
262PhosphorylationFQTNLVPYPRIHFPL
EECCCCCCCCCCCCC
9.5422817901
265UbiquitinationNLVPYPRIHFPLATY
CCCCCCCCCCCCCCC
3.20-
265UbiquitinationNLVPYPRIHFPLATY
CCCCCCCCCCCCCCC
3.2021963094
271PhosphorylationRIHFPLATYAPVISA
CCCCCCCCCCCCCCH
28.0921945579
272PhosphorylationIHFPLATYAPVISAE
CCCCCCCCCCCCCHH
11.8721945579
277PhosphorylationATYAPVISAEKAYHE
CCCCCCCCHHHHHHH
30.5221945579
277UbiquitinationATYAPVISAEKAYHE
CCCCCCCCHHHHHHH
30.5222817900
280AcetylationAPVISAEKAYHEQLS
CCCCCHHHHHHHHCC
54.7088225
280UbiquitinationAPVISAEKAYHEQLS
CCCCCHHHHHHHHCC
54.7021906983
282PhosphorylationVISAEKAYHEQLSVA
CCCHHHHHHHHCCHH
19.5625159151
287PhosphorylationKAYHEQLSVAEITNA
HHHHHHCCHHHHHHH
20.9822322096
289UbiquitinationYHEQLSVAEITNACF
HHHHCCHHHHHHHHC
10.0921890473
289NeddylationYHEQLSVAEITNACF
HHHHCCHHHHHHHHC
10.0932015554
289UbiquitinationYHEQLSVAEITNACF
HHHHCCHHHHHHHHC
10.0921963094
292PhosphorylationQLSVAEITNACFEPA
HCCHHHHHHHHCCCH
14.3130576142
295S-nitrosocysteineVAEITNACFEPANQM
HHHHHHHHCCCHHHC
4.27-
295GlutathionylationVAEITNACFEPANQM
HHHHHHHHCCCHHHC
4.2722555962
295S-nitrosylationVAEITNACFEPANQM
HHHHHHHHCCCHHHC
4.2720140087
296AcetylationAEITNACFEPANQMV
HHHHHHHCCCHHHCC
13.48-
296UbiquitinationAEITNACFEPANQMV
HHHHHHHCCCHHHCC
13.4821890473
296AcetylationAEITNACFEPANQMV
HHHHHHHCCCHHHCC
13.4819608861
296UbiquitinationAEITNACFEPANQMV
HHHHHHHCCCHHHCC
13.4821963094
304NeddylationEPANQMVKCDPRHGK
CCHHHCCCCCCCCCC
27.8132015554
304UbiquitinationEPANQMVKCDPRHGK
CCHHHCCCCCCCCCC
27.8121963094
311UbiquitinationKCDPRHGKYMACCLL
CCCCCCCCEEEEHHH
26.2321890473
311AcetylationKCDPRHGKYMACCLL
CCCCCCCCEEEEHHH
26.2319608861
311UbiquitinationKCDPRHGKYMACCLL
CCCCCCCCEEEEHHH
26.2323000965
312PhosphorylationCDPRHGKYMACCLLY
CCCCCCCEEEEHHHC
8.4428152594
315GlutathionylationRHGKYMACCLLYRGD
CCCCEEEEHHHCCCC
0.6722555962
319PhosphorylationYMACCLLYRGDVVPK
EEEEHHHCCCCCCCC
10.2923917254
321UbiquitinationACCLLYRGDVVPKDV
EEHHHCCCCCCCCCH
20.64-
321UbiquitinationACCLLYRGDVVPKDV
EEHHHCCCCCCCCCH
20.6432142685
323UbiquitinationCLLYRGDVVPKDVNA
HHHCCCCCCCCCHHH
9.8822817900
325PhosphorylationLYRGDVVPKDVNAAI
HCCCCCCCCCHHHHH
27.2932142685
326UbiquitinationYRGDVVPKDVNAAIA
CCCCCCCCCHHHHHH
63.8023000965
334PhosphorylationDVNAAIAAIKTKRSI
CHHHHHHHHHCCCCE
9.5632142685
336SumoylationNAAIAAIKTKRSIQF
HHHHHHHHCCCCEEE
43.18-
336AcetylationNAAIAAIKTKRSIQF
HHHHHHHHCCCCEEE
43.1826051181
336SumoylationNAAIAAIKTKRSIQF
HHHHHHHHCCCCEEE
43.18-
336UbiquitinationNAAIAAIKTKRSIQF
HHHHHHHHCCCCEEE
43.1821906983
337UbiquitinationAAIAAIKTKRSIQFV
HHHHHHHCCCCEEEE
26.10-
337NeddylationAAIAAIKTKRSIQFV
HHHHHHHCCCCEEEE
26.1032015554
337PhosphorylationAAIAAIKTKRSIQFV
HHHHHHHCCCCEEEE
26.1028464451
337UbiquitinationAAIAAIKTKRSIQFV
HHHHHHHCCCCEEEE
26.1021963094
338UbiquitinationAIAAIKTKRSIQFVD
HHHHHHCCCCEEEEE
38.8622817900
339MethylationIAAIKTKRSIQFVDW
HHHHHCCCCEEEEEE
44.20-
340PhosphorylationAAIKTKRSIQFVDWC
HHHHCCCCEEEEEEC
23.4626846344
347S-nitrosocysteineSIQFVDWCPTGFKVG
CEEEEEECCCCEEEE
1.55-
347GlutathionylationSIQFVDWCPTGFKVG
CEEEEEECCCCEEEE
1.5522555962
347S-nitrosylationSIQFVDWCPTGFKVG
CEEEEEECCCCEEEE
1.5520140087
347S-palmitoylationSIQFVDWCPTGFKVG
CEEEEEECCCCEEEE
1.5529575903
349PhosphorylationQFVDWCPTGFKVGIN
EEEEECCCCEEEEEE
52.7130266825
352AcetylationDWCPTGFKVGINYQP
EECCCCEEEEEECCC
40.68129723
352NeddylationDWCPTGFKVGINYQP
EECCCCEEEEEECCC
40.6832015554
352SumoylationDWCPTGFKVGINYQP
EECCCCEEEEEECCC
40.68-
352UbiquitinationDWCPTGFKVGINYQP
EECCCCEEEEEECCC
40.6821906983
355AcetylationPTGFKVGINYQPPTV
CCCEEEEEECCCCEE
4.93-
355UbiquitinationPTGFKVGINYQPPTV
CCCEEEEEECCCCEE
4.9321890473
355AcetylationPTGFKVGINYQPPTV
CCCEEEEEECCCCEE
4.9319608861
355NeddylationPTGFKVGINYQPPTV
CCCEEEEEECCCCEE
4.9332015554
355UbiquitinationPTGFKVGINYQPPTV
CCCEEEEEECCCCEE
4.9327667366
357NitrationGFKVGINYQPPTVVP
CEEEEEECCCCEECC
22.07-
357PhosphorylationGFKVGINYQPPTVVP
CEEEEEECCCCEECC
22.0727273156
361PhosphorylationGINYQPPTVVPGGDL
EEECCCCEECCCCCH
40.6028152594
370SumoylationVPGGDLAKVQRAVCM
CCCCCHHHHHHHHHH
46.31-
370AcetylationVPGGDLAKVQRAVCM
CCCCCHHHHHHHHHH
46.3119608861
370NeddylationVPGGDLAKVQRAVCM
CCCCCHHHHHHHHHH
46.3132015554
370SumoylationVPGGDLAKVQRAVCM
CCCCCHHHHHHHHHH
46.3119608861
370UbiquitinationVPGGDLAKVQRAVCM
CCCCCHHHHHHHHHH
46.3127667366
376S-nitrosocysteineAKVQRAVCMLSNTTA
HHHHHHHHHHCCHHH
1.90-
376GlutathionylationAKVQRAVCMLSNTTA
HHHHHHHHHHCCHHH
1.9022555962
376S-nitrosylationAKVQRAVCMLSNTTA
HHHHHHHHHHCCHHH
1.9020140087
379UbiquitinationQRAVCMLSNTTAIAE
HHHHHHHCCHHHHHH
12.7821890473
379AcetylationQRAVCMLSNTTAIAE
HHHHHHHCCHHHHHH
12.7819608861
379PhosphorylationQRAVCMLSNTTAIAE
HHHHHHHCCHHHHHH
12.7819664995
379UbiquitinationQRAVCMLSNTTAIAE
HHHHHHHCCHHHHHH
12.7832142685
381PhosphorylationAVCMLSNTTAIAEAW
HHHHHCCHHHHHHHH
17.7730108239
382PhosphorylationVCMLSNTTAIAEAWA
HHHHCCHHHHHHHHH
21.9530108239
386UbiquitinationSNTTAIAEAWARLDH
CCHHHHHHHHHHCCC
38.33-
386AcetylationSNTTAIAEAWARLDH
CCHHHHHHHHHHCCC
38.3319608861
386UbiquitinationSNTTAIAEAWARLDH
CCHHHHHHHHHHCCC
38.3321963094
394SumoylationAWARLDHKFDLMYAK
HHHHCCCCCCHHHEE
39.99-
394AcetylationAWARLDHKFDLMYAK
HHHHCCCCCCHHHEE
39.9919608861
394SumoylationAWARLDHKFDLMYAK
HHHHCCCCCCHHHEE
39.9919608861
394UbiquitinationAWARLDHKFDLMYAK
HHHHCCCCCCHHHEE
39.9932142685
399PhosphorylationDHKFDLMYAKRAFVH
CCCCCHHHEEEHHHH
19.1028674151
401SumoylationKFDLMYAKRAFVHWY
CCCHHHEEEHHHHHH
27.11-
401AcetylationKFDLMYAKRAFVHWY
CCCHHHEEEHHHHHH
27.11129731
401SumoylationKFDLMYAKRAFVHWY
CCCHHHEEEHHHHHH
27.1119608861
401UbiquitinationKFDLMYAKRAFVHWY
CCCHHHEEEHHHHHH
27.1121963094
408PhosphorylationKRAFVHWYVGEGMEE
EEHHHHHHCCCCCCC
5.4528796482
413SulfoxidationHWYVGEGMEEGEFSE
HHHCCCCCCCCCHHH
3.5428183972
415UbiquitinationYVGEGMEEGEFSEAR
HCCCCCCCCCHHHHH
55.95-
415UbiquitinationYVGEGMEEGEFSEAR
HCCCCCCCCCHHHHH
55.9522817900
419PhosphorylationGMEEGEFSEAREDMA
CCCCCCHHHHHHHHH
26.5028270605
430UbiquitinationEDMAALEKDYEEVGI
HHHHHHHHCHHHHCC
67.4722817900
432PhosphorylationMAALEKDYEEVGIDS
HHHHHHCHHHHCCCC
25.6720044836
439O-linked_GlycosylationYEEVGIDSYEDEDEG
HHHHCCCCCCCCCCC
28.6229351928
439PhosphorylationYEEVGIDSYEDEDEG
HHHHCCCCCCCCCCC
28.6222817900
440PhosphorylationEEVGIDSYEDEDEGE
HHHCCCCCCCCCCCC
24.5322817900

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of TBA4A_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
40KAcetylation

24906155
40KMethylation

24906155

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of TBA4A_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
TBB5_HUMANTUBBphysical
22939629
TBB2A_HUMANTUBB2Aphysical
22939629
TBB3_HUMANTUBB3physical
22939629
TBB4B_HUMANTUBB4Bphysical
22939629
PRPS1_HUMANPRPS1physical
22863883
RS27A_HUMANRPS27Aphysical
22863883
TRXR1_HUMANTXNRD1physical
22863883
MGRN1_HUMANMGRN1physical
24556679
TAU_HUMANMAPTphysical
24251416
PYR1_HUMANCADphysical
26344197
EF1A1_HUMANEEF1A1physical
26344197
HNRPK_HUMANHNRNPKphysical
26344197
PRP8_HUMANPRPF8physical
26344197
PSMD1_HUMANPSMD1physical
26344197
RUVB1_HUMANRUVBL1physical
26344197
RUVB2_HUMANRUVBL2physical
26344197
TBB5_HUMANTUBBphysical
26344197
TBB2A_HUMANTUBB2Aphysical
26344197
TBB2B_HUMANTUBB2Bphysical
26344197
TBB3_HUMANTUBB3physical
26344197
T11L2_HUMANTCP11L2physical
28514442
DLGP5_HUMANDLGAP5physical
28514442
TBB3_HUMANTUBB3physical
28514442
TCPH_HUMANCCT7physical
28514442
DAAM1_HUMANDAAM1physical
28514442
TKT_HUMANTKTphysical
28514442

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
616208Amyotrophic lateral sclerosis 22, with or without frontotemporal dementia (ALS22)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
DB06772Cabazitaxel
DB01179Podofilox
DB00541Vincristine
Regulatory Network of TBA4A_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-163 AND LYS-311, AND MASSSPECTROMETRY.
Phosphorylation
ReferencePubMed
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-48 AND SER-340, AND MASSSPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-48 AND SER-340, AND MASSSPECTROMETRY.
"Phosphoproteome of resting human platelets.";
Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.;
J. Proteome Res. 7:526-534(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-439 AND TYR-440, ANDMASS SPECTROMETRY.
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.";
Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
J. Proteome Res. 6:4150-4162(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-161, AND MASSSPECTROMETRY.
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells.";
Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.;
Nat. Biotechnol. 23:94-101(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-272, AND MASSSPECTROMETRY.

TOP